Eremid Genomic Services

Executive Summary

Eremid Genomic Services is a US-based contract research organization (CRO) that provides specialized genomics and bioinformatics services to clients in AgBiotech, Food & Nutrition, and Human Health. Founded in 2014 and headquartered in Charlottesville, Virginia, the company operates CLIA-certified and CAP-accredited laboratories, enabling it to support both research and clinical applications. Eremid offers end-to-end project support, from experimental design and sample processing to data delivery and interpretation, positioning itself as a comprehensive partner for genomic analysis. With the growing demand for outsourced genomics services in precision agriculture, food safety, and human diagnostics, Eremid is well-placed to capture market share. The company's multi-sector focus and accredited infrastructure provide a competitive edge, though its private status limits visibility into financial performance. As a pre-clinical stage company, Eremid's near-term growth will depend on expanding its client base and service offerings.

Upcoming Catalysts (preview)

• H2 2026Expansion of CLIA/CAP-accredited lab capacity or service menu70% success
• H1 2027Strategic partnership with a major agbiotech or food company50% success
• 2027Launch of a new bioinformatics platform or AI-driven data analysis service60% success